- Início
- Program
Program
*Subject to chance without notice.
Nov 1st
| Time | Topic | Speaker | Debater | Moderator |
|---|---|---|---|---|
| 08h00 | Solenidade de Abertura | |||
| 08h30 - 08h45 | Opening Conference I: “Prof Henry H. Neufeld”. Innovative and Efficient Clinical Trial Models with Pharmacological Interventions for Cardiovascular Diseases. | Prof. Dr. Otavio Berwanger | ||
| 08h45 - 09h00 | Opening Conference II "The Era of Direct Oral Anticoagulants: The importance of Getting the Right Dose | Prof. Dr. Renato Lopes | ||
| 09h00 - 10h00 | Lipid-lowering therapy | Dr. Francisco Fonseca | ||
| 09h00 - 09h15 | Lipid-lowering targets and therapy in patients with ACS and CCS | Dra. Maria Cristina Izar | ||
| 09h15 - 09h30 | Lipid-lowering targets and therapy in patients with DM | Dr. Alberto Lorenzatti | ||
| 09h30 - 09h45 | What should we do when statins are not enough? | Dr. Antony Martínez-Rubio | ||
| 09h45 - 10h00 | Debate | |||
| 10h00 - 10h30 | Coffee Break | |||
| 10h30 - 11h30 | Satellite Symposium Medtronic | Dr. Celso Amodeo | ||
| 10h30 - 10h45 | Fundamentos da RDN: A hiperatividade simpática renal como fator gerador de HTA resistente | Dr. Luciano Drager | ||
| 10h45 - 11h05 | Evidência clínica do procedimento de DNR com o cateter Symplicity Spyral: Um novo dispositivo com uma tecnica otimizada. | Dr. Valério Fucs | ||
| 11h05 - 11h20 | Critério de seleção do paciente com HTA resistente candidato a DNR: O que dizem as diretrizes e consensos atuais? | Dr. João Vicente | ||
| 11h20 - 11h30 | Discussão | Todos | ||
| 11h30 - 12h30 | JOINT SESSION ISCP-SIAC Personalized Medicine: the Future is Now |
Dr. Alvaro Sosa Liprandi Pablo Avanza |
||
| 11h30 - 11h45 | New Strategies for Resistant Hypertension | Dr. Thomas Kahan | ||
| 11h45 - 12h00 | Polypill in Clinical Practice: What are we Waiting For? | Dr. Alvaro Sosa Liprandi | ||
| 12h00 - 12h15 | Familial Hypercholesterolemia, new Opportunities for Difficult Patients | Dr. Rodrigo Alonso | ||
| 12h15 - 12h30 | Debate | Dra. Maria Cristina Izar Dr. Luiz Bortolotto |
||
| 12h30 - 13h30 | Satellite Symposium Mantecorp: "Differences in Vitamin D and its benefits for cardiovascular health." | Dr. Francisco Fonseca | Dr. Celso Amodeo | |
| 13h30 - 14h30 | Combination of antihypertensive medications | Dr. Wilson Nadruz Dr. Audes Feitosa |
||
| 14h30 - 15h30 | Satellite Symposium GSK - Cardiovascular outcomes associated with infections and the role of immunization in protecting cardiac patients. | Dra. Maisa Kairalla Dr. José Carlos da Costa Zanon |
||
| 15h30 - 16h00 | Coffee Break | |||
| 16h00 - 17h00 | Heart Failure Session | |||
| 16h00 - 16h15 | Pharmacological Pillars of HFrEF therapy | Dr. Felipe Martinez | ||
| 16h15 - 16h30 | Advanced Pharmacological approuch in HFpEF | Dr. Francisco Saraiva | ||
| 16h30 - 16h45 | Acta non Verba: barriers in implementing GDMT IN HFrEF management | Dr. George Dan | ||
| 16h45 - 17h00 | Debate | Dr. Evandro Tinoco Dr. Felix Ramires |
||
| 17h00 - 18h00 | Miscellaneous topics: Hormones and Drugs | Dr. Audes Feitosa | ||
| 17h00 - 17h15 | The impact new generations (GLP-1 agonists and dual GIP/GLP-1 agonisms) on weight and CV outcomes | Dr. Francisco Saraiva | ||
| 17h15 - 17h30 | Benefits of beta-3 adrenergic agonism on the CV system | Dra. Andrea Brandão | ||
| 17h30 - 17h45 | Cardiovascular disease in transgender individuals | Dr. Wilson Nadruz | ||
| 17h45 - 18h00 | Debate | Dr. Abrão Cury Dr Oswaldo Passarelli Jr |
||
| 18h00 - 19h00 | Atrial Fibrillation Session | Dr. Weverton Leite | ||
| 18h00 - 18h15 | DOACs use in AF in 2024 | Dr. Alvaro Avezum | ||
| 18h15 - 18h30 | Antithrombotic strategies after ACS and AF | Dr. Luis Machado | ||
| 18h30 - 18h45 | Reversion or heart rate control in patients with AF? | Dr. Tasso Lobo | ||
| 18h45 - 19h00 | Debate | Dr. Nelson Siqueira | ||
| Scientific Session | |
| Scientific Session | |
| Coffe Break | |
| Satellite Symposium |
Nov 2nd
| Time | Topic | Speaker | Debater | Moderator |
|---|---|---|---|---|
| 08h30 - 09h30 | JOINT SESSION ISCP-WHF Pharmacotherapy Potpourri | Dr. Evandro Tinoco Dr. Alvaro Sosa Liprandi |
||
| 08h30 - 08h45 | HF Prevention, What is in the Horizon? | Dr. Felipe Martínez | ||
| 08h45 - 09h00 | Flu Shot and CV Disease, as Important as Statin? | Dr. Alvaro Sosa Liprandi | ||
| 09h00 - 09h15 | Novel Oral Anticoagulants and Emerging Agents | Dr. Antony Martínez-Rubio | ||
| 09h15 - 09h30 | Debate | Dr. Thomas Kaham Dr. Pablo Avanzas |
||
| 09h30 - 10h30 | Innovations in vascular ageing and hypertension | Dr. Mauricio Wangarten | ||
| 09h30 - 10h00 | Oscillometric devices for vascular ageing and central blood pressure parameters and evaluation | Dr. Weimar K. Sebba Barroso de Souza | ||
| 10h00 - 10h15 | Emerging antihypertensive classes: What can we expect for the future? | Dr. Wilson Nadruz | ||
| 10h15 - 10h30 | RNA interference strategies for the treatment of hypertension | Dr. Luciano Drager | ||
| 10h30 - 11h00 | Coffee Break | |||
| 11h00 - 12h00 | Inflammation in CVD | Dr. Ricardo Pavanello | ||
| 11h00 - 11h15 | Anti-Inflammatory therapy in atherosclerosis | Dr. Francisco Fonseca | ||
| 11h15 - 11h30 | Colchicine in chronic and acute coronary syndromes | Dr. Otavio Rizzi Coelho | ||
| 11h30 - 11h45 | Anti-Inflammatory therapy in HF | Dr. Koji Hasegawa | ||
| 11h45 - 12h00 | Debate | Dr. Luis Gowdak Dr. Antonio Carlos Pallandri Chagas |
||
| 12h00 - 13h00 | Satellite symposium Daiichi-Sankyo: "The future of hypertension: Olmesartan triple therapy and orodispersible pharmaceutical technology." | Dr. Celso Amodeo | ||
| 13h00 - 14h00 | Metabolic Associated Fatty Liver Disease (MAFLD) | Dr. Abrão Cury | ||
| 13h00 - 13h15 | How to diagnosis MAFLD | Dr. Bruno Geloneze | ||
| 13h15 - 13h45 | MAFLD and CV risk and therapy | Dr. Franscisco Saraiva | ||
| 13h45 - 14h00 | Debate | Dra. Egle Costa | ||
| 14h00 - 15h00 | Antithrombotics | Dr. Edson Stefanini | ||
| 14h00 - 14h15 | Drugs Interactions of DOACS | Dra. Doreen Tan | ||
| 14h15 - 14h30 | Bleeding risk and reversers of antithrombotics | Dr. Luis Fernando Tanajura | ||
| 14h30 - 14h45 | Warfarin indications in 2024 | Dr. Pavanello | ||
| 14h45 - 15h00 | Debate | Dr. Antony Martínez-Rubio | ||
| 15h00 - 16h00 | JOINT SESSION ISCP/SBC Cardiovascular Prevention |
Dr. Antonio Carlos Pallandri Chagas | ||
| 15h00 - 15h15 | Cognitive decline and brain damage: How to evaluate? | Dr. Weimar K. Sebba Barroso de Souza | ||
| 15h15 - 15h30 | Polypills in Hypertension | Dra. Andrea Brandão | ||
| 15h30 - 15h45 | Refractory Angine: New Concepts | Dr. Juan Carlos Kaski | ||
| 15h45 - 16h00 | Debate | Dr. Ricardo Pavanello Dr. Evandro Tinoco |
||
| 16h00 - 17h00 | Cardiomyopathies Therapy | Dr. Fabio Fernandes | ||
| 16h00 - 16h15 | Hypertrophic cardiomyopathy | Dr. Dirceu Rodrigues de Almeida | ||
| 16h15 - 16h30 | Amyloidosis | Dra. Edileide Barros | ||
| 16h30 - 16h45 | Cardiac manifestations of sarcoidosis and potential impact of treatment | Dr. Fabio Fernandes | ||
| 16h45 - 17h00 | Pharmacological Pillars of HFmrEF therapy | Dr. Fernando Bacal | ||
| 17h00 - 18h00 | Obesity and cardiovascular health: challenges e solutions in the XXI century | Dr. Celso Amodeo | ||
| 17h00 - 17h20 | Bariatric surgery: what are the indications in 2024? | Dr. Luciano Drager | ||
| 17h20 - 17h40 | Pipeline and perpectives for new molecules | Dr. Bruno Geloneze | ||
| 17h40 - 18h00 | Discussion |
| Scientific Session | |
| Scientific Session | |
| Coffe Break | |
| Satellite Symposium |
Português
English